HOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
By Mary Gabb (mary.gabb@rxcomms.com) “There just isn’t, and never will be, enough money to provide every possible service” – a reminder to participants of the NICE Citizens Council (November 27–29,…
Details
By Robert Hand (robert.hand@rxcomm) As of the beginning of this year, the American Medical Writers Association (AMWA) has added its code of ethics to membership application and renewal materials. New…
Details
By Julie Stauffer (julie.stauffer@rxcomms.com) You’ve scrutinized the data, crunched the numbers and arrived at a solid risk assessment. But how do you communicate that information so that great-aunt Betty can…
Details
By Mary Gabb (mary.gabb@rxcomms.com) January 1, 2009 – typically a day of new beginnings – marked the beginning of the end of SWAG (stuff we all get, or freebies) for…
Details
By David Woods (hmi3000@comcast.net) The European Union is moving to strengthen rights of EU patients to seek care in countries other than their own, while the UK government has stated…
Details
With President-elect Obama’s proposed plan to reform the US healthcare system, this will be the closest the US has gotten to universal health coverage. We provide a snapshot of the Obama healthcare plan and highlight some of the criticisms it has received from health economists.
Details
By David Woods (hmi3000@comcast.net) With healthcare in the US consuming about 16% of GNP, or around 2 trillion dollars a year, and still leaving an estimated 47 million people uninsured,…
Details
By Mary Gabb (mary.gabb@rxcomms.com) The UK ‘s National Institute for Health and Clinical Excellence (NICE) has recently ruled that four drugs used to treat advanced kidney cancer are not effective…
Details
By Ruth Whittington (ruth.whittington@rxcomms.com) Rx Communications has just returned triumphant from the 11th annual European Congress of ISPOR. ISPOR is a great place to meet old friends, find new ones,…
Details
By Julie Stauffer (julie.stauffer@rxcomms.com) Pharmaceutical companies produce hundreds of life-saving drugs every year. Yet each year, millions of people in developing countries die from preventable and treatable illnesses – diseases…
Details
